MARKET

MDCX

MDCX

Medicus Pharma Ltd
NASDAQ
1.530
+0.020
+1.32%
After Hours: 1.520 -0.01 -0.65% 19:09 12/31 EST
OPEN
1.570
PREV CLOSE
1.510
HIGH
1.620
LOW
1.500
VOLUME
401.16K
TURNOVER
--
52 WEEK HIGH
8.94
52 WEEK LOW
1.450
MARKET CAP
33.70M
P/E (TTM)
-0.7755
1D
5D
1M
3M
1Y
5Y
1D
Medicus Pharma Launches At-the-Market Equity Offering Program
TipRanks · 12/30/2025 14:47
MEDICUS PHARMA LTD - TO OFFER SHARES UP TO $15.35 MLN - SEC FILING
Reuters · 12/30/2025 14:28
MEDICUS PHARMA LTD - TO OFFER SECURITIES WORTH UP TO $100 MLN - SEC FILING
Reuters · 12/30/2025 11:04
Weekly Report: what happened at MDCX last week (1222-1226)?
Weekly Report · 12/29/2025 09:59
Maxim Group Remains a Buy on Medicus Pharma Ltd (MDCX)
TipRanks · 12/23/2025 12:55
Medicus Pharma Taps Reliant AI for Data-Driven Teverelix Clinical Development
TipRanks · 12/22/2025 14:27
MEDICUS PHARMA LTD <MDCX.O>: MAXIM GROUP CUTS TARGET PRICE TO $12 FROM $20
Reuters · 12/22/2025 13:00
Medicus Pharma enters non-binding LOI with Reliant AI
TipRanks · 12/22/2025 12:46
More
About MDCX
Medicus Pharma Ltd. is a biotech/life sciences company focused on accelerating the clinical development programs of novel and disruptive therapeutics assets. SkinJect Inc., a wholly owned subsidiary of the Company, is a development stage, life sciences company focused on commercializing novel, non-invasive treatment for basal cell skin cancer using a patented dissolvable microneedle patch to deliver a chemotherapeutic agent to eradicate tumors cells. It is conducting a randomized, controlled, double-blind, multicenter clinical study (SKNJCT-003) in the United States and Europe. It has also commenced a randomized, controlled, double-blind, multicenter clinical study (SKNJCT-004) in the UAE. Its subsidiary, Antev Limited, is a late clinical stage biotech company, developing Teverelix, a GnRH antagonist, as a first in market product for cardiovascular high-risk advanced prostate cancer patients and patients with first acute urinary retention relapse episodes due to enlarged prostate.

Webull offers Medicus Pharma Ltd stock information, including NASDAQ: MDCX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MDCX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MDCX stock methods without spending real money on the virtual paper trading platform.